| 1 | [SID3711253] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. [AID2016, Type: screening] | MEP2 [Saccharomyces cerevisiae] [gi:1302091] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. | | AID | 2016 | | BioAssay type | screening | | Target | MEP2 [Saccharomyces cerevisiae] [gi:1302091] | | PubMed | | | Data Table |  |
|
| 2 | [SID3711253] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 3 | [SID3711253] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 4 | [SID3711253] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 5 | [SID3711253] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 6 | [SID3711253] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 7 | [SID3711253] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 8 | [SID3711253] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 9 | [SID3711253] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 10 | [SID3711253] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 11 | [SID3711253] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 12 | [SID3711253] | Active | | | Late stage assay provider results from the probe development effort to identify inhibitors of Protein Arginine Deiminase 4 (PAD4): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition by HTS hits of PADs 1-4 [AID588487_4, Type: other] | PADI4 gene product [Homo sapiens] [gi:216548487] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify inhibitors of Protein Arginine Deiminase 4 (PAD4): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition by HTS hits of PADs 1-4 | | AID | 588487 | | BioAssay type | other | | Target | PADI4 gene product [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 13 | [SID3711253] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 14 | [SID3711253] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 15 | [SID3711253] | Active | | | Late stage assay provider results from the probe development effort to identify inhibitors of Protein Arginine Deiminase 4 (PAD4): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition by HTS hits of PADs 1-4 [AID588487, Type: other] | PADI1 gene product [Homo sapiens] [gi:122056685] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify inhibitors of Protein Arginine Deiminase 4 (PAD4): fluorescence-based biochemical gel-based competitive Activity-Based Protein Profiling (ABPP) inhibition by HTS hits of PADs 1-4 | | AID | 588487 | | BioAssay type | other | | Target | PADI1 gene product [Homo sapiens] [gi:122056685] | | PubMed | | | Data Table |  |
|
| 16 | [SID3711253] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A) [AID623877, Type: screening] | Ano1 gene product [Mus musculus] [gi:334278898] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A) | | AID | 623877 | | BioAssay type | screening | | Target | Ano1 gene product [Mus musculus] [gi:334278898] | | PubMed | | | Data Table |  |
|
| 17 | [SID3711253] | Active | | | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay [AID504720, Type: screening] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay | | AID | 504720 | | BioAssay type | screening | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|
| 18 | [SID3711253] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1). [AID1950, Type: screening] | EBNA-1 protein [Human herpesvirus 4] [gi:23893623] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1). | | AID | 1950 | | BioAssay type | screening | | Target | EBNA-1 protein [Human herpesvirus 4] [gi:23893623] | | PubMed | | | Data Table |  |
|
| 19 | [SID3711253] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. [AID2025, Type: screening] | RPL19A [Saccharomyces cerevisiae] [gi:536029] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. | | AID | 2025 | | BioAssay type | screening | | Target | RPL19A [Saccharomyces cerevisiae] [gi:536029] | | PubMed | | | Data Table |  |
|
| 20 | [SID3711253] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 21 | [SID3711253] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 22 | [SID3711253] | Inactive | Potency | 35.4813 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 23 | [SID3711253] | Inactive | Potency | 35.4813 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 24 | [SID3711253] | Inactive | EC50 | 99 | Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay counterscreen [AID588502, Type: confirmatory] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | EC50 | 99 [uM] | | BioAssay | Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay counterscreen | | AID | 588502 | | BioAssay type | confirmatory | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|
| 25 | [SID3711253] | Inactive | EC50 | 99 | Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay [AID588481, Type: confirmatory] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | EC50 | 99 [uM] | | BioAssay | Dose response confirmation uHTS hits for MazEF TA System activators via a fluorescence-based single-stranded RNase assay | | AID | 588481 | | BioAssay type | confirmatory | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|
| 26 | [SID3711253] | Inactive | | | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage) [AID651602, Type: screening] | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage) | | AID | 651602 | | BioAssay type | screening | | Target | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] | | PubMed | | | Data Table |  |
|
| 27 | [SID3711253] | Inactive | | | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity [AID488895, Type: screening] | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488895 | | BioAssay type | screening | | Target | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] | | PubMed | | | Data Table |  |
|
| 28 | [SID3711253] | Inactive | | | uHTS identification of inhibitors of NadD in a Colorimetric assay [AID602399, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | uHTS identification of inhibitors of NadD in a Colorimetric assay | | AID | 602399 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 29 | [SID3711253] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set [AID588501, Type: Literature] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | | AID | 588501 | | BioAssay type | Literature | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | 16604538 | | Data Table |  |
|
| 30 | [SID3711253] | Inactive | Potency | | qHTS Assay for Anthrax Lethal Toxin Internalization [AID912, Type: confirmatory] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Anthrax Lethal Toxin Internalization | | AID | 912 | | BioAssay type | confirmatory | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | | | Data Table |  |
|
| 31 | [SID3711253] | Inactive | | | Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity [AID504884, Type: screening] | DNA topoisomerase I [Yersinia pestis CO92] [gi:115347926] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504884 | | BioAssay type | screening | | Target | DNA topoisomerase I [Yersinia pestis CO92] [gi:115347926] | | PubMed | | | Data Table |  |
|
| 32 | [SID3711253] | Inactive | | | YopH HTS [AID898, Type: screening] | YopH [Yersinia enterocolitica] [gi:28373018] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | YopH HTS | | AID | 898 | | BioAssay type | screening | | Target | YopH [Yersinia enterocolitica] [gi:28373018] | | PubMed | | | Data Table |  |
|
| 33 | [SID3711253] | Inactive | IC50 | | Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents [AID1903, Type: confirmatory] | large T antigen [Simian virus 40] [gi:297591903] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents | | AID | 1903 | | BioAssay type | confirmatory | | Target | large T antigen [Simian virus 40] [gi:297591903] | | PubMed | | | Data Table |  |
|
| 34 | [SID3711253] | Inactive | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 35 | [SID3711253] | Inactive | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 36 | [SID3711253] | Inactive | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 37 | [SID3711253] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 38 | [SID3711253] | Inactive | | | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity [AID540336, Type: screening] | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 540336 | | BioAssay type | screening | | Target | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] | | PubMed | | | Data Table |  |
|
| 39 | [SID3711253] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). [AID1962, Type: screening] | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). | | AID | 1962 | | BioAssay type | screening | | Target | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] | | PubMed | | | Data Table |  |
|
| 40 | [SID3711253] | Inactive | Potency | | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 41 | [SID3711253] | Inactive | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624268, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624268 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 42 | [SID3711253] | Inactive | | | HTS assay for inhibitors of Trypanosoma brucei hexokinase 1 [AID1430, Type: screening] | hexokinase [Trypanosoma brucei] [gi:70832125] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | HTS assay for inhibitors of Trypanosoma brucei hexokinase 1 | | AID | 1430 | | BioAssay type | screening | | Target | hexokinase [Trypanosoma brucei] [gi:70832125] | | PubMed | | | Data Table |  |
|
| 43 | [SID3711253] | Inactive | | | Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA. [AID2234, Type: screening] | BZLF1 [Human herpesvirus 4] [gi:82503229] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA. | | AID | 2234 | | BioAssay type | screening | | Target | BZLF1 [Human herpesvirus 4] [gi:82503229] | | PubMed | | | Data Table |  |
|
| 44 | [SID3711253] | Inactive | | | Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity [AID504558, Type: screening] | LMP1 [Human herpesvirus 4] [gi:23893668] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504558 | | BioAssay type | screening | | Target | LMP1 [Human herpesvirus 4] [gi:23893668] | | PubMed | | | Data Table |  |
|
| 45 | [SID3711253] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase [AID602233, Type: confirmatory] | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase | | AID | 602233 | | BioAssay type | confirmatory | | Target | phosphoglycerate kinase [Trypanosoma brucei] [gi:115503961] | | PubMed | | | Data Table |  |
|
| 46 | [SID3711253] | Inactive | | | Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC [AID556, Type: screening] | diphosphomevalonate decarboxylase [Streptococcus pneumoniae D39] [gi:116076351] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC | | AID | 556 | | BioAssay type | screening | | Target | diphosphomevalonate decarboxylase [Streptococcus pneumoniae D39] [gi:116076351] | | PubMed | | | Data Table |  |
|
| 47 | [SID3711253] | Inactive | | | Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC [AID556, Type: screening] | diphosphomevalonate decarboxylase [Streptococcus pneumoniae D39] [gi:116076351] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC | | AID | 556 | | BioAssay type | screening | | Target | diphosphomevalonate decarboxylase [Streptococcus pneumoniae D39] [gi:116076351] | | PubMed | | | Data Table |  |
|
| 48 | [SID3711253] | Inactive | | | Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK [AID539, Type: screening] | phosphomevalonate kinase [Streptococcus pneumoniae D39] [gi:116077694] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK | | AID | 539 | | BioAssay type | screening | | Target | phosphomevalonate kinase [Streptococcus pneumoniae D39] [gi:116077694] | | PubMed | | | Data Table |  |
|
| 49 | [SID3711253] | Inactive | | | Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK [AID555, Type: screening] | mevalonate kinase [Streptococcus pneumoniae D39] [gi:116516899] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK | | AID | 555 | | BioAssay type | screening | | Target | mevalonate kinase [Streptococcus pneumoniae D39] [gi:116516899] | | PubMed | | | Data Table |  |
|
| 50 | [SID3711253] | Inactive | | | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction [AID2629, Type: screening] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 3711253 | | CID | 2997571 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 2629 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|